Review



trigno control utility software version 3 6 0  (Delsys Inc)


Bioz Verified Symbol Delsys Inc is a verified supplier
Bioz Manufacturer Symbol Delsys Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Delsys Inc trigno control utility software version 3 6 0
    Trigno Control Utility Software Version 3 6 0, supplied by Delsys Inc, used in various techniques. Bioz Stars score: 94/100, based on 27 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/utility/Trigno+Control+Utility/pm41865071-531-2-8
    Average 94 stars, based on 27 article reviews
    trigno control utility software version 3 6 0 - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Control:

    Article Title: Longitudinal assessment of chemotherapy-induced peripheral neuropathy in women undergoing taxane-based treatment for breast cancer: a prospective observational study.
    Article Snippet: Sway Accelerometer A wireless sensor (Trigno® Wireless Biofeedback System, Delsys Inc., Manchester, UK) was attached to the participants’ lower back at the level of the posterior superior iliac spine. .. While participants performed a 30-s static bipedal balance test barefoot with feet shoulder-width apart, accelerations were sampled at 148 Hz by tri-axial accelerometery and recorded in Labchart 8 (ADInstruments, Oxford, UK) via Trigno Control Utility plugin (Delsys Inc.). ..

    Article Title: Longitudinal assessment of chemotherapy-induced peripheral neuropathy in women undergoing taxane-based treatment for breast cancer: a prospective observational study
    Article Snippet: A wireless sensor (Trigno ® Wireless Biofeedback System, Delsys Inc., Manchester, UK) was attached to the participants’ lower back at the level of the posterior superior iliac spine. .. While participants performed a 30-s static bipedal balance test barefoot with feet shoulder-width apart, accelerations were sampled at 148 Hz by tri-axial accelerometery and recorded in Labchart 8 (ADInstruments, Oxford, UK) via Trigno Control Utility plug-in (Delsys Inc.). ..

    Article Title: Assessment of artificial intelligence-based control algorithms to be implemented in an affordable transradial myoelectric prosthesis.
    Article Snippet: .. The sensors were connected to a laptop running Windows via a USB cable, and communication was handled using TCP/IP protocols through the Trigno Control Utility software version 3.6.0 (Delsys Inc., Natick, MA, USA)59. ..

    Article Title: Assessment of artificial intelligence-based control algorithms to be implemented in an affordable transradial myoelectric prosthesis.
    Article Snippet: .. Delsys Inc. Trigno control utility software version 3.6.0. https://delsys.com/support/trigno-sdk/ (2025). ..

    Article Title: Effects of first-step constraints on multi-muscle synergies and early postural adjustments during step initiation.
    Article Snippet: EMG signals were collected using a wireless electromyography system (Trigno Avanti, Delsys Inc.) configured with an embedded hardware band-pass filter of 20–450 Hz. .. Integration and stream control of EMG data within the LabVIEW environment were executed using the Delsys Trigno Development Kit (TDK). ..

    Software:

    Article Title: Assessment of artificial intelligence-based control algorithms to be implemented in an affordable transradial myoelectric prosthesis.
    Article Snippet: .. The sensors were connected to a laptop running Windows via a USB cable, and communication was handled using TCP/IP protocols through the Trigno Control Utility software version 3.6.0 (Delsys Inc., Natick, MA, USA)59. ..

    Article Title: Online performance evaluation of a four-degree-of-freedom musculoskeletal model based on muscle synergy
    Article Snippet: Traditional control strategies of electromyography (EMG)-based human-machine interfaces are confined to single degree-of-freedom (DoF) activation and suffer from a lack of robustness, while existing multi-DoF approaches encounter difficulties in real-time control and generalizability across different users.. To overcome these limitations, we propose a generic 4-DoF musculoskeletal model grounded in muscle synergy theory, designed to enable synchronous proportional control of four DoFs in the wrist and metacarpophalangeal joints.. A ‘‘divide and conquer’’ strategy is adopted, and non-negative matrix factorization is leveraged to extract muscle synergies and estimate muscle activation levels.

    Article Title: Assessment of artificial intelligence-based control algorithms to be implemented in an affordable transradial myoelectric prosthesis.
    Article Snippet: .. Delsys Inc. Trigno control utility software version 3.6.0. https://delsys.com/support/trigno-sdk/ (2025). ..



    Similar Products

    delsys trigno development kit  (Delsys Inc)
    94
    Delsys Inc delsys trigno development kit
    Delsys Trigno Development Kit, supplied by Delsys Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/utility/Trigno+Control+Utility/pm42900225-76-15-15
    Average 94 stars, based on 1 article reviews
    delsys trigno development kit - by Bioz Stars, 2026-11
    94/100 stars
    		  Buy from Supplier
    200 suspension chip multiplex detection system utilizes bead based dual fluorescence labeling  (DiaSorin Biotechnology)
    99
    DiaSorin Biotechnology 200 suspension chip multiplex detection system utilizes bead based dual fluorescence labeling
    200 Suspension Chip Multiplex Detection System Utilizes Bead Based Dual Fluorescence Labeling, supplied by DiaSorin Biotechnology, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/utility/Luminex+200+System/10__1007_slash_s10989___026___10866___8-216-2-1
    Average 99 stars, based on 1 article reviews
    200 suspension chip multiplex detection system utilizes bead based dual fluorescence labeling - by Bioz Stars, 2026-11
    99/100 stars
    		  Buy from Supplier
    rna seq utilizes illumina sequencing  (Plasmidsaurus)
    99
    Plasmidsaurus rna seq utilizes illumina sequencing
    Rna Seq Utilizes Illumina Sequencing, supplied by Plasmidsaurus, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/utility/RNA-Seq/pm42595906-538-2-1
    Average 99 stars, based on 1 article reviews
    rna seq utilizes illumina sequencing - by Bioz Stars, 2026-11
    99/100 stars
    		  Buy from Supplier
    pradhan mantri jan arogya yojana increased utilization  (Arogya Inc)
    86
    Arogya Inc pradhan mantri jan arogya yojana increased utilization
    Pradhan Mantri Jan Arogya Yojana Increased Utilization, supplied by Arogya Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/utility/arogya+jan+mantri+pradhan+yojana/pmc13264029-37-9-12
    Average 86 stars, based on 1 article reviews
    pradhan mantri jan arogya yojana increased utilization - by Bioz Stars, 2026-11
    86/100 stars
    		  Buy from Supplier
    immunohistochemical staining utilized pcna  (ABclonal Biotechnology)
    93
    ABclonal Biotechnology immunohistochemical staining utilized pcna
    a was created by Figdraw. a , b Treatment schedule of the GL261 mouse brain tumor model (by figdraw.com). The detailed treatment sequence and time points. c , d Brain images of each group of mice obtained by T2 magnetic resonance imaging (MRI) with different treatments, where tumors are circled in white dashed lines. e-g <t>Immunohistochemical</t> images of tumor sections were examined at 15 days (Ki67 and <t>PCNA,</t> n = 5). h Survival curves of GBM tumor-bearing mice in different treatment groups ( n = 10). Survival analysis was calculated using the log-rank test. i Body weight changes of GBM tumor-bearing mice in different treatment groups ( n = 10). j , k Evaluation of antitumor effects of different treatments. n = 5 samples per group for data in ( c-f ) and ( i-k ). Data are expressed as the mean ± SD. Statistical significances were determined using one-way ANOVA with Fisher’s LSD post‑hoc test. Comparisons were performed between different groups in ( c-f ) and ( i-k ). Not significant (NS) is P ≥ 0.05, and significant P values are shown. n = 10 samples per group for data in ( h ). Survival analysis was compared using the log-rank test. Source data are provided as a file.
    Immunohistochemical Staining Utilized Pcna, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/utility/PCNA+Mouse+mAb/pmc13526793-823-0-8
    Average 93 stars, based on 1 article reviews
    immunohistochemical staining utilized pcna - by Bioz Stars, 2026-11
    93/100 stars
    		  Buy from Supplier
    quantitative pcr process utilized chamq sybr qpcr master mix  (Vazyme Biotech Co)
    99
    Vazyme Biotech Co quantitative pcr process utilized chamq sybr qpcr master mix
    a was created by Figdraw. a , b Treatment schedule of the GL261 mouse brain tumor model (by figdraw.com). The detailed treatment sequence and time points. c , d Brain images of each group of mice obtained by T2 magnetic resonance imaging (MRI) with different treatments, where tumors are circled in white dashed lines. e-g <t>Immunohistochemical</t> images of tumor sections were examined at 15 days (Ki67 and <t>PCNA,</t> n = 5). h Survival curves of GBM tumor-bearing mice in different treatment groups ( n = 10). Survival analysis was calculated using the log-rank test. i Body weight changes of GBM tumor-bearing mice in different treatment groups ( n = 10). j , k Evaluation of antitumor effects of different treatments. n = 5 samples per group for data in ( c-f ) and ( i-k ). Data are expressed as the mean ± SD. Statistical significances were determined using one-way ANOVA with Fisher’s LSD post‑hoc test. Comparisons were performed between different groups in ( c-f ) and ( i-k ). Not significant (NS) is P ≥ 0.05, and significant P values are shown. n = 10 samples per group for data in ( h ). Survival analysis was compared using the log-rank test. Source data are provided as a file.
    Quantitative Pcr Process Utilized Chamq Sybr Qpcr Master Mix, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/utility/ChamQ+SYBR+qPCR+Master+Mix/pm41413714-56-1-11
    Average 99 stars, based on 1 article reviews
    quantitative pcr process utilized chamq sybr qpcr master mix - by Bioz Stars, 2026-11
    99/100 stars
    		  Buy from Supplier
    statistical processing utilized graphpad prism 8  (GraphPad Software Inc)
    99
    GraphPad Software Inc statistical processing utilized graphpad prism 8
    a was created by Figdraw. a , b Treatment schedule of the GL261 mouse brain tumor model (by figdraw.com). The detailed treatment sequence and time points. c , d Brain images of each group of mice obtained by T2 magnetic resonance imaging (MRI) with different treatments, where tumors are circled in white dashed lines. e-g <t>Immunohistochemical</t> images of tumor sections were examined at 15 days (Ki67 and <t>PCNA,</t> n = 5). h Survival curves of GBM tumor-bearing mice in different treatment groups ( n = 10). Survival analysis was calculated using the log-rank test. i Body weight changes of GBM tumor-bearing mice in different treatment groups ( n = 10). j , k Evaluation of antitumor effects of different treatments. n = 5 samples per group for data in ( c-f ) and ( i-k ). Data are expressed as the mean ± SD. Statistical significances were determined using one-way ANOVA with Fisher’s LSD post‑hoc test. Comparisons were performed between different groups in ( c-f ) and ( i-k ). Not significant (NS) is P ≥ 0.05, and significant P values are shown. n = 10 samples per group for data in ( h ). Survival analysis was compared using the log-rank test. Source data are provided as a file.
    Statistical Processing Utilized Graphpad Prism 8, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/utility/Prism+8/pm41980611-142-0-3
    Average 99 stars, based on 1 article reviews
    statistical processing utilized graphpad prism 8 - by Bioz Stars, 2026-11
    99/100 stars
    		  Buy from Supplier
    treatment utilized poractant alfa  (Chiesi)
    86
    Chiesi treatment utilized poractant alfa
    a was created by Figdraw. a , b Treatment schedule of the GL261 mouse brain tumor model (by figdraw.com). The detailed treatment sequence and time points. c , d Brain images of each group of mice obtained by T2 magnetic resonance imaging (MRI) with different treatments, where tumors are circled in white dashed lines. e-g <t>Immunohistochemical</t> images of tumor sections were examined at 15 days (Ki67 and <t>PCNA,</t> n = 5). h Survival curves of GBM tumor-bearing mice in different treatment groups ( n = 10). Survival analysis was calculated using the log-rank test. i Body weight changes of GBM tumor-bearing mice in different treatment groups ( n = 10). j , k Evaluation of antitumor effects of different treatments. n = 5 samples per group for data in ( c-f ) and ( i-k ). Data are expressed as the mean ± SD. Statistical significances were determined using one-way ANOVA with Fisher’s LSD post‑hoc test. Comparisons were performed between different groups in ( c-f ) and ( i-k ). Not significant (NS) is P ≥ 0.05, and significant P values are shown. n = 10 samples per group for data in ( h ). Survival analysis was compared using the log-rank test. Source data are provided as a file.
    Treatment Utilized Poractant Alfa, supplied by Chiesi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/utility/alfa+poractant/pm42316154-71-1-6
    Average 86 stars, based on 1 article reviews
    treatment utilized poractant alfa - by Bioz Stars, 2026-11
    86/100 stars
    		  Buy from Supplier
    utility  (Galectin Therapeutics)
    86
    Galectin Therapeutics utility
    a was created by Figdraw. a , b Treatment schedule of the GL261 mouse brain tumor model (by figdraw.com). The detailed treatment sequence and time points. c , d Brain images of each group of mice obtained by T2 magnetic resonance imaging (MRI) with different treatments, where tumors are circled in white dashed lines. e-g <t>Immunohistochemical</t> images of tumor sections were examined at 15 days (Ki67 and <t>PCNA,</t> n = 5). h Survival curves of GBM tumor-bearing mice in different treatment groups ( n = 10). Survival analysis was calculated using the log-rank test. i Body weight changes of GBM tumor-bearing mice in different treatment groups ( n = 10). j , k Evaluation of antitumor effects of different treatments. n = 5 samples per group for data in ( c-f ) and ( i-k ). Data are expressed as the mean ± SD. Statistical significances were determined using one-way ANOVA with Fisher’s LSD post‑hoc test. Comparisons were performed between different groups in ( c-f ) and ( i-k ). Not significant (NS) is P ≥ 0.05, and significant P values are shown. n = 10 samples per group for data in ( h ). Survival analysis was compared using the log-rank test. Source data are provided as a file.
    Utility, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/utility/pm42278921-240-3-5
    Average 86 stars, based on 1 article reviews
    utility - by Bioz Stars, 2026-11
    86/100 stars
    		  Buy from Supplier
    resource utilization  (Anhui Medical University)
    86
    Anhui Medical University resource utilization
    a was created by Figdraw. a , b Treatment schedule of the GL261 mouse brain tumor model (by figdraw.com). The detailed treatment sequence and time points. c , d Brain images of each group of mice obtained by T2 magnetic resonance imaging (MRI) with different treatments, where tumors are circled in white dashed lines. e-g <t>Immunohistochemical</t> images of tumor sections were examined at 15 days (Ki67 and <t>PCNA,</t> n = 5). h Survival curves of GBM tumor-bearing mice in different treatment groups ( n = 10). Survival analysis was calculated using the log-rank test. i Body weight changes of GBM tumor-bearing mice in different treatment groups ( n = 10). j , k Evaluation of antitumor effects of different treatments. n = 5 samples per group for data in ( c-f ) and ( i-k ). Data are expressed as the mean ± SD. Statistical significances were determined using one-way ANOVA with Fisher’s LSD post‑hoc test. Comparisons were performed between different groups in ( c-f ) and ( i-k ). Not significant (NS) is P ≥ 0.05, and significant P values are shown. n = 10 samples per group for data in ( h ). Survival analysis was compared using the log-rank test. Source data are provided as a file.
    Resource Utilization, supplied by Anhui Medical University, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/utility/resource+utilization/pm42265069-30-9-11
    Average 86 stars, based on 1 article reviews
    resource utilization - by Bioz Stars, 2026-11
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    a was created by Figdraw. a , b Treatment schedule of the GL261 mouse brain tumor model (by figdraw.com). The detailed treatment sequence and time points. c , d Brain images of each group of mice obtained by T2 magnetic resonance imaging (MRI) with different treatments, where tumors are circled in white dashed lines. e-g Immunohistochemical images of tumor sections were examined at 15 days (Ki67 and PCNA, n = 5). h Survival curves of GBM tumor-bearing mice in different treatment groups ( n = 10). Survival analysis was calculated using the log-rank test. i Body weight changes of GBM tumor-bearing mice in different treatment groups ( n = 10). j , k Evaluation of antitumor effects of different treatments. n = 5 samples per group for data in ( c-f ) and ( i-k ). Data are expressed as the mean ± SD. Statistical significances were determined using one-way ANOVA with Fisher’s LSD post‑hoc test. Comparisons were performed between different groups in ( c-f ) and ( i-k ). Not significant (NS) is P ≥ 0.05, and significant P values are shown. n = 10 samples per group for data in ( h ). Survival analysis was compared using the log-rank test. Source data are provided as a file.

    Journal: Nature Communications

    Article Title: Low-intensity pulsed ultrasound-mediated nose-to-brain co-delivery of β-blockers and aPD-L1 enhances glioblastoma immunotherapy

    doi: 10.1038/s41467-026-76103-4

    Figure Lengend Snippet: a was created by Figdraw. a , b Treatment schedule of the GL261 mouse brain tumor model (by figdraw.com). The detailed treatment sequence and time points. c , d Brain images of each group of mice obtained by T2 magnetic resonance imaging (MRI) with different treatments, where tumors are circled in white dashed lines. e-g Immunohistochemical images of tumor sections were examined at 15 days (Ki67 and PCNA, n = 5). h Survival curves of GBM tumor-bearing mice in different treatment groups ( n = 10). Survival analysis was calculated using the log-rank test. i Body weight changes of GBM tumor-bearing mice in different treatment groups ( n = 10). j , k Evaluation of antitumor effects of different treatments. n = 5 samples per group for data in ( c-f ) and ( i-k ). Data are expressed as the mean ± SD. Statistical significances were determined using one-way ANOVA with Fisher’s LSD post‑hoc test. Comparisons were performed between different groups in ( c-f ) and ( i-k ). Not significant (NS) is P ≥ 0.05, and significant P values are shown. n = 10 samples per group for data in ( h ). Survival analysis was compared using the log-rank test. Source data are provided as a file.

    Article Snippet: Immunohistochemical staining utilized PCNA (AC058, PCNA Mouse mAb, Abclonal) and Ki67 (A26755PM, Ki67 Rabbit PolymAb®, Abclonal) antibodies, with technical assistance from Nanjing Youmeng Biotechnology Co., Ltd. Tumor sections underwent immunofluorescence staining using a TUNEL assay kit (Beyotime Biotech, Shanghai, China).

    Techniques: Sequencing, Magnetic Resonance Imaging, Immunohistochemical staining